Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2012: Case Study  

Ophthalmic manifestation of skull base metastasis from breast cancer

Diana Anna Dmuchowska ABCDEF , Pawel Krasnicki BCDE , Iwona Obuchowska CD , Jan Kochanowicz DE , Anna Syta-Krzyżanowska BD , Zofia Mariak CDE

DOI: 10.12659/MSM.883532

Med Sci Monit 2012; 18(11): CS105-108

0 Comments

Background

In patients with systemic cancer, there is a vast discrepancy between the frequency of skull base metastases reported in vivo (4%) [1] and at autopsy (22%) [2]. This difference seems to be related to the fact that most of these metastases are either asymptomatic or their symptoms are unspecific, making the diagnosis difficult, particularly in patients without known history of cancer [1]. The most common primary sites of cancer are breast (21%), followed by lung, and prostate [2].

The size, location, and rate of growth, and not the character of the lesion itself, determine the clinical presentation of the skull base tumor. The signs and symptoms arise from the stretching of the dura, compression of cranial nerves, irritation (with resulting edema) of the adjacent brain tissue, and, rarely, occlusion of the dural venous sinuses. Greenberg et al. [3] described 5 clinical syndromes caused by skull base lesions. The orbital and parasellar syndromes are characterized by diplopia, supraorbital frontal headache, and sensory loss in the region of the ophthalmic nerve. Proptosis and decreased vision occur in the orbital syndrome. The clinical and radiological appearance of skull base metastasis sometimes mimic a primary lesion such as meningioma.

Early detection of skull base metastases is vital, as timely surgery may influence patient quality of life and rate of survival. Careful ophthalmologic examination may provide such an opportunity in a situation when the infiltration reaches the cranial nerves serving the visual system. In this account, we report the case of a patient with skull base metastasis, in whom ophthalmic examination helped in establishing the diagnosis.

Case Report

A 53-year-old woman presented to the ophthalmology emergency room with a 10-day history of ptosis and a 1-week history of diplopia. Additionally, she complained of skin numbness in the right half of the forehead up to the hairline, and dry eye on the right side. Aside from systemic hypertension and obesity, the medical history was unremarkable. Neither the patient nor the family noticed any other worrisome symptoms or signs, including psychological or psychiatric complaints.

On ophthalmic examination, eye movement assessment revealed elevation and slight adduction deficit, with proper depression and abduction (Figure 1). Proptosis (17 mm vs. 15 mm) and corneal hypoesthesia on the right side were noted. The patient had visual acuity of 20/20 and intraocular pressure of 17 mmHg on both sides, with normal pupillary reflexes, pupil diameter, and color vision. The anterior and posterior segments of the eye were normal; no signs of papilledema or venous stasis were observed.

Head CT and MRI (Figure 2) revealed an extensive abnormal mass within the right frontal sinus, penetrating to the orbit, adhering to the superior and medial recti muscles, with no compression of the optic nerve. The mass infiltrated the medial-upper wall of the orbit, stretching along the orbital roof and causing its hyperostosis, thus appearing as a meningioma “en plaque”. The lesion crossed the lesser sphenoid wing and formed a globular mass within the anterior aspect of the middle cranial fossa. The upper orbital fissure seemed not to be occupied by the tumor. The tumor caused massive edema of the adjacent aspects of the frontal and temporal lobes of the brain.

A comprehensive neurological examination was performed. Apart from partial oculomotor nerve palsy and palsy of the ophthalmic division of the trigeminal nerve, no abnormalities were detected. The level of CA 15–3, a tumor marker indicative of breast cancer, was elevated. Mammography and breast ultrasonography revealed a structure suggestive of cancer, but biopsy proved negative. Otherwise, the systemic screening was negative.

Explorative craniotomy was undertaken because meningioma “en plaque” was suspected and the symptomatic character of the lesion prompted a final diagnosis. Partial resection confined to the globular part of the lesion was achieved. Histopathological examination revealed breast cancer metastasis. The patient received palliative radiation therapy.

Discussion

In this case report, we would like to emphasize the role of the ophthalmologist as the professional responsible for initiating the diagnostic process. In spite of the extensive cranial base infiltration and concomitant brain edema, the patient presented signs and symptoms limited solely to partial involvement of the oculomotor and ophthalmic nerves. This was the only manifestation of an undetected skull base tumor.

The presence of ptosis and elevation deficit pointed to the palsy of the superior division of the oculomotor nerve. Furthermore, the region of hypoesthesia, involving the skin and cornea, as well as the dry eye, suggested a palsy of all 3 branches (frontal, nasociliary, and lacrimal) of the ophthalmic division of the trigeminal nerve. The elevation and adduction deficit, accompanied by proptosis, could be attributed to the mass effect within the upper and medial part of the orbit. Consequently, the signs and symptoms were consistent with orbital and parasellar syndromes.

Early and proper diagnosis of skull base tumors is of utmost importance in achieving effective treatment and survival. Despite the availability of advanced imaging techniques, there remains a vast discrepancy between the frequency of skull base metastases reported in vivo and at autopsy [2]. This discrepancy exists because clinical signs and symptoms of the anterior skull base infiltration are vague and highly unspecific. Some of these symptoms (such as diplopia, ptosis, proptosis, supraorbital frontal headache, and sensory loss in the region of the ophthalmic nerve) have been clustered into the orbital and parasellar syndrome. It should be noted, however, that familiarity with this symptomatology, especially of its potential etiological background, is not part of the common competence of the ophthalmologist. For that reason, awareness is fundamental. The possibility of a skull base tumor must be kept in mind among other, more frequent, causes of palsy of the nerves supplying the eye and the adnexa.

Conclusions

Orbital and parasellar syndromes consisting of diplopia, ptosis, proptosis, and sensory loss in the region of the ophthalmic nerve may be the only manifestation of a skull base metastasis. Careful ophthalmologic examination is crucial in early detection of this life-threatening condition.

References

1. Laigle-Donadey F, Taillibert S, Martin-Duverneuil N, Skull-base metastases: J Neurooncol, 2005; 75; 63-69, pmid: 16215817

2. Gloria-Cruz TI, Schachern PA, Paparella MM, Metastases to temporal bones from primary nonsystemic malignant neoplasms: Arch Otolaryngol Head Neck Surg, 2000; 126; 209-14, pmid: 10680873

3. Greenberg HS, Deck MD, Vikram B, Metastasis to the base of the skull: Clinical findings in 43 patients: Neurology, 1981; 31; 530-37, pmid: 6972014

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750